Efficacy and Safety of the Novel Dipeptidyl Peptidase-4 Inhibitor Gemigliptin in the Management of Type 2 Diabetes: A Meta-Analysis

BACKGROUND: No meta-analysis has holistically analysed and summarised the efficacy and safety of gemigliptin in type 2 diabetes. The meta-analysis addresses this knowledge gap. METHODS: Electronic databases were searched for randomised controlled trials (RCTs) involving diabetes patients receiving g...

Descripción completa

Detalles Bibliográficos
Autores principales: Dutta, Deep, Agarwal, Anshita, Maisnam, Indira, Singla, Rajiv, Khandelwal, Deepak, Sharma, Meha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090470/
https://www.ncbi.nlm.nih.gov/pubmed/33820392
http://dx.doi.org/10.3803/EnM.2020.818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090470/
https://www.ncbi.nlm.nih.gov/pubmed/33820392
http://dx.doi.org/10.3803/EnM.2020.818

Ejemplares similares